Ligand Reports Fourth Quarter and Full Year 2017 Financial Results
Go back to Ligand Reports Fourth Quarter and Full Year 2017 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 285.54 -3.71 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $289.25 | 52 Week High | $139.79 | |||
| Open | $291.48 | 52 Week Low | $82.07 | |||
| Day High | $294.00 | P/E | 664.05 | |||
| Day Low | $283.77 | EPS | $0.43 | |||
| Volume | 111,586 | |||||
